Lv5
870 积分 2023-04-07 加入
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)
8天前
已完结
The value and safety of adjuvant radiotherapy (ART) after radical cystectomy in locally advanced urothelial bladder cancer: A controlled randomized study
13天前
已完结
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
1个月前
已完结
Pharmacokinetics of Ceftazidime‐Avibactam in Two Patients With KPC‐Producing Klebsiella pneumoniae Bacteremia and Renal Impairment
1个月前
已完结
Successful rescue treatment of sepsis due to a pandrug-resistant, NDM-producing Klebsiella pneumoniae using aztreonam powder for nebulizer solution as intravenous therapy in combination with ceftazidime/avibactam
1个月前
已完结
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa
1个月前
已完结
Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
2个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
2个月前
已完结
Daraxonrasib Doubles OS for PDAC in Phase III Trial
2个月前
已完结
皖公网安备34019202002308
